MICHELLE BARTHE: Open Payments
NPI 1952706947 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 16 payments from 9 companies in 2025. Trend: 2023 $120 · 2024 $18 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $104 |
| INTUITIVE SURGICAL, INC. | 1 | $85 |
| Astellas Pharma US Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $31 |
| Corcept Therapeutics | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, Da Vinci Surgical System, Veozah, MOUNJARO, Korlym, XIFAXAN, Rybelsus, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
